Rockville, MD · Health Care · Form D filed Oct 7, 2026No press found
Templar Nova, Inc. raised $7M
Templar Nova, Inc. is a biotechnology company based in Rockville, Maryland. In a Form D filed with the SEC on October 7, 2026, it reported raising $7,000,000 from 2 investors as part of an offering of up to $7,000,000. The first sale in the offering took place on September 28, 2026.
No press found. No news article or press release about this raise turned up when we searched on October 17, 2026. Announcements sometimes come weeks after a filing, so we check again. More raises with no press found
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$7M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 7, 2026 | $7M | $7M | 2 |
Lead score
56 out of 100
filed recently first raise ever budget to spend no press yet young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $7,000,000
- Offering size
- $7,000,000
- Investors so far
- 2
- Minimum investment
- $7,000,000
- First sale
- September 28, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Rockville, Maryland
- Incorporated
- Delaware, 2026
- Entity type
- Corporation
- Revenue range
- Not Applicable
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $7,000,000 | $7,000,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Oct 5, 2026 · Health Care funding in Maryland
Similar raises
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
LeanOnWe Care, Inc.
Rockville, MD · filed Sep 10First Form D
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising
Functional Longevity Labs, Inc.
Easton, MD · filed Sep 21First Form DStill raising